Alzheimer’s: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Medicare has severely restricted access to the medication Leqembi, which costs $26,500 per year, because the FDA approved it just on an expedited basis.
Supreme Court decision on Biden’s student loan forgiveness plan is key for those who never finish college
The Supreme Court’s decision on student loan forgiveness will be especially meaningful for borrowers who never earned a diploma.
Move over Red Bull and Monster. This energy drink stock may be the next big industry breakout, Piper Sandler says
The Wall Street firm initiated coverage of this stock with an overweight rating, as well as a $110 price target.
Chrysler parent Stellantis offering buyouts to 33,500 U.S. employees
The buyouts will be offered to 31,000 hourly employees and 2,500 salaried nonunion U.S. employees, the automaker said Wednesday.
California’s reappearing phantom lake could remain for two years in the Central Valley
Tulare Lake could trigger billions of dollars in economic losses and displace thousands of farmers.
Bipartisan bill would require parental consent for minors to use social media
The bill also would create a pilot program for a new, age-verification credential that could be used to enroll on social media platforms.
‘I’m here because Trump raped me’: E. Jean Carroll begins trial testimony
Former President Donald Trump denies claims in a civil suit from writer E. Jean Carroll that he raped her in a New York department store, and defamed her.
How to get hired in a tough job market — tips for the class of 2023
Four tips to help college students navigate a tough job market — and land that first job.
Meta shares pop 12% after company reports first sales increase in four quarters, issues optimistic guidance
Facebook parent Meta reported revenue for the first quarter that topped estimates and issued a forecast for the second quarter that also exceeded expectations.
